Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group
Published Online: 17 OCT 2007
Assessed as up-to-date: 28 FEB 2006
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Heirs M, Dean ME. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005648. DOI: 10.1002/14651858.CD005648.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 17 OCT 2007
Homeopathy is one form of complementary/alternative medicine which is promoted as being a safe and effective form of treatment for children and adults. Within the UK homeopathy use is estimated at 1.9% of the adult population (Thomas 2004), and around 11% for children under 16 years (Simpson 2001). There has been increased interest in homeopathy's potential as a non-pharmacological intervention for attention deficit/hyperactivity disorder as an alternative to the use of stimulant medications such as Ritalin. Homeopathy is a system of medicine based on the principle of treating "like with like" using various dilutions of natural or man-made substances. Homeopathy focuses on the unique characteristics of each patient's experience and symptomatology and uses this information to determine the appropriate prescription for each patient.
To assess the safety and effectiveness of homeopathy as a treatment for attention deficit/hyperactivity disorder.
We searched a wide set of databases from their inception to March 2006 including: CENTRAL, MEDLINE, AMED, BIOSIS, CISCOM, CINAHL, Dissertation Abstracts, ECH (European Committee for Homeopathy thesis database), EMBASE, ERIC, HomInform (Glasgow Homeopathic Hospital Library), LILACS, PsycINFO, Science Citation Index, SIGLE, GIRI - International congress on ultra-low doses, Liga Medicorum Homeopathica Internationalis.
We contacted experts in the field about ongoing or current research.
All studies where individualised, clinical or formula homeopathy had been used to treat participants with ADHD or HKD who were randomly or quasi-randomly allocated to either true treatment or a control were selected. Control groups could include wait-list, no treatment, medication, placebo homeopathy, educational or behavioural interventions.
Data collection and analysis
Data from four eligible studies (total n = 168) were extracted and entered into RevMan. Results were synthesised and estimates of the effect sizes were calculated and presented as appropriate (using standardised mean differences) in both graphical and narrative form (narrative only was used where no effect size calculation was possible).
The forms of homeopathy evaluated to date do not suggest significant treatment effects for the global symptoms, core symptoms of inattention, hyperactivity or impulsivity, or related outcomes such as anxiety in Attention Deficit/Hyperactivity Disorder.
There is currently little evidence for the efficacy of homeopathy for the treatment of ADHD. Development of optimal treatment protocols is recommended prior to further randomised controlled trials being undertaken.
Plain language summary
Homeopathy for ADHD
This review aimed to assess the evidence for homeopathy as an intervention for attention deficit/hyperactivity disorder. Four trials were retrieved and assessed with mixed results. Overall the results of this review found no evidence of effectiveness for homeopathy for the global symptoms, core symptoms or related outcomes of attention deficit/hyperactivity disorder.
用順勢療法治療注意力缺陷/過動症 (ADHD) 或過度活躍症 (HKD)
順勢療法可以補救/替代藥物治療,因為對兒童和成年人安全和有效而被大力提倡.英國順勢療法的使用估計佔1.9% 成人人口 (Thomas 2004), 和約11% 的16歲以下兒童人口 (Simpson 2001). 越來越多研究將順勢療法作為非藥物介入,治療注意力缺陷/過動症 (ADHD), 希望取代像Ritalin等刺激性藥物.順勢療法是稀釋各種自然物質或人造物質,用 ‘以毒攻毒’ 理論的一系列療法.順勢療法針對每位病人獨特的經驗和症狀特點,決定適合每位病人的處方.
廣泛蒐尋以下資料庫 (由資料庫開始到2006年三月的資料): CENTRAL, MEDLINE, AMED, BIOSIS, CISCOM, CINAHL, Dissertation Abstracts, ECH (European Committee for Homeopathy thesis database), EMBASE, ERIC, HomInform (Glasgow Homeopathic Hospital Library), LILACS, PsycINFO, Science Citation Index, SIGLE, GIRI關於極低劑量的國際會議, Liga Medicorum Homeopathica Internationalis.連絡本領域專家關於正在進行的研究資料.
挑出四個符合條件的試驗 (總共168為受試者) 納入RevMan.綜合這些結果，效應量 (effect size) 的估計值經計算，視以圖形或文字型式何者適用 (用標準平均差) 呈現於文獻中 (不能計算效應量時則僅以文字敘述) 。
目前評估過的順勢治療的形式,對所有症狀,核心症狀 (不能專心,過動,激動) 或相關結果如ADHD焦慮,都並沒有顯著療效.
此翻譯計畫由臺灣國家衛生研究院 (National Health Research Institutes, Taiwan) 統籌。